EVDx

EVDx is a biotechnology company specializing in the development of advanced liquid biopsy platforms centered on extracellular vesicles (EVs), commonly known as exosomes. The company utilizes proprietary microfluidic technology to isolate and molecularly profile EVs from blood samples, enabling early-stage detection and monitoring of various cancers and infectious diseases. Their primary focus includes high-mortality diseases such as pancreatic and ovarian cancer, as well as rapid diagnostics for viral pathogens. By leveraging the unique biomarkers found within exosomes, EVDx aims to provide non-invasive, highly sensitive diagnostic tools that outperform traditional imaging and protein-based assays. The company is a spin-off from the University of Florida and has received significant support through federal research grants.